premenstrual syndrome. Premenstrual tension syndrome
Conditions
Interventions
Intervention 1: Intervention group: Primerose oil capsule 1000 mg twice a day from 14 days before menstruation to 5 days after menstruation for two consecutive cycles. Intervention 2: Intervention gro
Treatment - Drugs
Placebo
Intervention group: Primerose oil capsule 1000 mg twice a day from 14 days before menstruation to 5 days after menstruation for two consecutive cycles
Intervention group: Vitamin D capsule 40 mg twice a day from 14 days before menstruation to 5 days after menstruation for two consecutive cycles
Control group: Placebo capsule twice a day from 14 days before menstruation to 5 days after menstruation for two consecutive cycles
Sponsors
Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: age of 18 to 35 years; having regular menstrual cycle with 21 to 35 days interval. Exclusion criteria: physical disease or using medications; psychological disease; using anti-depression drugs during past months; using hormonal drugs or vitamins.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of symptoms of premenstrual syndrome. Timepoint: before intervention and 1 and 2 months after intervention. Method of measurement: using standard diagnostic questionnaire for premenstrual syndrome. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactArezoo Shayan
School of Nursing and Midwifery
Outcome results
None listed